PREFRAIL

Clinical trials for PREFRAIL explained in plain language.

Never miss a new study

Get alerted when new PREFRAIL trials appear

Sign up with your email to follow new studies for PREFRAIL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

HIV frailty breakthrough? D+Q combo tested in phase 2 trial

Disease control Ongoing

This study tests whether a combination of two drugs, dasatinib and quercetin (D+Q), can safely improve physical function in people aged 50 and older with HIV who are frail or prefrail. About 80 participants will receive either D+Q or a placebo over 12 weeks, then be monitored for…

Matched conditions: PREFRAIL

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated May 11, 2026 20:51 UTC

PREFRAIL

Get alerted when new PREFRAIL trials appear

HIV frailty breakthrough? D+Q combo tested in phase 2 trial